Article Details

Gilteritinib-Azacitidine Tested in R/R FLT3-Mutated AML

Retrieved on: 2020-12-05 20:02:45

Tags for this article:

Click the tags to see associated articles and topics

Gilteritinib-Azacitidine Tested in R/R FLT3-Mutated AML. View article details on hiswai:

Excerpt

At <b>data analysis</b>, 61% of the patients in the randomization cohort had died. The median treatment duration was 4 cycles. “As the study progresses, ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up